Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Tolenix (THVD-201)
print preview
bookmark
share with colleague
General Information
Company
TheraVida Inc.
Description
Modified-release formulation of tolterodine and pilocarpine
Molecular Target
Muscarinic receptor
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Incontinence
Partner
SK Chemicals Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information